ORAMED PHARMACEUTICALS INC
Reported by THE BANK OF NEW YORK MELLON CORPORATION
First reported at 79,255 shares this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 1170000 |
| 2022-03-31 | 841000 |
| 2022-06-30 | 0 |
| 2026-06-30 | 381217 |
| 2026-09-30 | 370121 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Unchanged | 79,255 | 0 (0.0%) | < 0.01% | $370,121 | 2026-11-05 | |
| Q2 2026 | New | 79,255 | +79,255 (0.0%) | < 0.01% | $381,217 | 2026-08-06 | |
| Q2 2022 | Reduced | 0 | -97,214 (-100.0%) | 0 | $0 | 2022-08-15 | |
| Q1 2022 | Added | 97,214 | +15,296 (18.7%) | < 0.01% | $841,000 | 2022-05-11 | |
| Q4 2021 | Added | 81,918 | +11,772 (16.8%) | < 0.01% | $1,170,000 | 2022-02-11 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
93 managers reported ORAMED PHARMACEUTICALS INC for Q2 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| MERCER GLOBAL ADVISORS INC ADV | Added | 3,810,540 | +1,900,000 | 0.02% | $18,328,697 | 2 qtrs |
| Aquamarine Financial Cayman Ltd | Added | 2,512,175 | +399,863 | 0.67% | $12,083,562 | 4 qtrs |
| Gem Investment Advisors LLC | Added | 1,998,802 | +358,733 | 5.89% | $9,614,238 | 3 qtrs |
| BlackRock Inc | Added | 1,608,111 | +1,515,919 | < 0.01% | $7,735,015 | 8 qtrs |
| Murchinson Ltd | Reduced | 1,290,294 | -25,000 | 0.86% | $6,206,314 | 11 qtrs |
| BML Capital Management LLC | Reduced | 866,269 | -2,300,962 | 2.37% | $4,166,754 | 14 qtrs |
| BOOTHBAY FUND MANAGEMENT LLC | Reduced | 578,638 | -22,078 | 0.04% | $2,783,249 | 11 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 500,690 | +476,408 | < 0.01% | $2,408,318 | 29 qtrs |
| The Goldman Sachs Group Inc | New | 253,293 | +253,293 | < 0.01% | $1,218,339 | 1 qtr |
| STATE STREET CORPORATION | New | 242,100 | +242,100 | < 0.01% | $1,164,501 | 1 qtr |
Filing details and methodology As reported
- Report period
- June 30, 2026
- Filed
- August 06, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 68,076
- Shared
- 0
- None
- 11,179
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.